By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300




Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 


Massachusetts Life Sciences Center 

Company News
Amid Takeover Talks With Johnson & Johnson (JNJ), Actelion (ALIOF.PK)'s Hypertension Drug Flunks Key Phase III Test 1/23/2017 5:31:01 AM
5 Most Important Drugs To Johnson & Johnson (JNJ) In 2017 1/19/2017 7:06:59 AM
A Look at Whether Johnson & Johnson (JNJ) Passes Warren Buffet's Acquisition Test 1/17/2017 6:46:26 AM
Johnson & Johnson (JNJ)'s DePuy Synthes Issues Recall 1/13/2017 6:52:29 AM
Johnson & Johnson (JNJ)’s Device Subsidiary Gets Into Value-Based Analytics 1/11/2017 7:41:51 AM
How Trump Can Propel Johnson & Johnson (JNJ) to New Heights 1/11/2017 6:31:13 AM
Sanofi (SNY) Sees No Opening to Actelion (ALIOF.PK) Talks After Johnson & Johnson (JNJ) Steps Back in 1/10/2017 6:42:44 AM
Starting 2017 With a Bang, Johnson & Johnson (JNJ) Touts 15 New Collaborations 1/5/2017 7:05:58 AM
Judge Halves $1 Billion Award In Johnson & Johnson (JNJ) Hip Implants Case 1/4/2017 7:23:59 AM
Johnson & Johnson (JNJ)'s DePuy Synthes Buys Technology From Interventional Spine for Undisclosed Sum 1/3/2017 10:34:49 AM